Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 8, 2011, Pages 2019-2023

  Zhao, Pengcheng ^a   Lin, Fengsong ^b   Li, Zhe ^a   Lin, Baisong ^a   Lin, Jing ^c   Luo, Rongcheng ^c  

^a JILIN UNIVERSITY   (China)

^b TIANJIN HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Esophageal cancer risk; Folate intake; Methylenetetrahydrofolate reductase polymorphism

Indexed keywords

EID: 84863250795     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bai JL, Zheng MH, Xia X, et al (2009). MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: a meta-analysis of 3511 cases and 2762 controls. Eur J Cancer, 46, 1443-9.
2. Bailey L B, Gregory JF. (1999). 3rd Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr, 129, 919-22.
3. Blount BC, Mack MM, Wehr CM, et al (2007). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-5.
4. Boccia S, Gianfagna F, Persiani R, et al (2007). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers, 12, 635-44.
5. Cao HX, Gao CM, Takezaki T, et al (2008). Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac J Cancer Prev, 9, 203-8.
6. Chen HTK, Graubard BI, Heineman EF, et al (2002). Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer, 42, 33-40.
7. Choi SW, Mason JB. (2000). Folate and carcinogenesis: an integrated scheme. J Nutr, 130, 129-32.
8. Fang JY, Xiao SD. (2003). Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. J Gastroenterol, 38, 821-9.
9. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a commonmutation inmethylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
10. He Y, Wang Y, Zhang J, et al (2007). Correlation between a polymorphism in the methylene tetrahydrofolate reductase gene and susceptibility to carcinoma of the esophagus and gastric cardia. Chinese J Clin Oncol, 34, 194-7.
11. Kim YI. (2004). Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev, 13, 511-9.
12. Langevin SM, Lin D, Matsuo K, et al (2009). Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett, 184, 73-80.
13. Leclerc D, Rozen R. (2007). Molecular genetics of MTHFR: polymorphisms are not all benign. Med Sci, 23, 297-302.
14. Li DQ, Diao YT, Li H, Fang XQ, Li HQ. (2008). Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma. Arch Med Res, 39, 594-600.
15. Mayne ST, Risch HA, Dubrow R, et al (2001). Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev, 10, 1055-62.
16. Miller SA, Dykes DD, Polesky HF. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
17. Qin JM, Yang L, Chen B, et al (2008). Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol, 14, 6986-6992.
18. Sarbia M, Stahl M, vonWeyhern C, Weirich G, Puhringer-Oppermann F (2006). The prognostic significance of genetic polymorphisms (methylenetetrahydrofolate reductase C677T, methionine synthase A2756G, thymidilate synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma. Br J Cancer, 94, 203-7.
19. Song C, Xing D, Tan W, Wei Q, Lin D. (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 61, 3272-5.
20. Stern LL, Mason JB, Selhub J, Choi SW. (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53.
21. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, et al (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev, 12, 1222-6.
22. Suzuki T, Matsuo K, Hasegawa Y, et al (2007). One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci, 98, 1439-46.
23. Umar M, Upadhyay R, Khurana R, et al (2010). Evaluation of MTHFR677C>T polymorphism in prediction and prognosis of esophageal squamous cell carcinoma: a case-control study in a northern Indian population. Nutr Cancer, 62, 743-9.
24. Wang LD, Guo RF, Fan ZM, et al (2005). Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus, 18, 177-84.
25. Wang Y, Guo W, He Y, et al (2007). Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control, 18, 143-52.
26. Weinstein SJ, Gridley G, Harty LC, et al (2002). Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR)C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr, 132, 762-7.
27. Wilcken B, Bamforth F, Li Z, et al (2003). Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet, 40, 619-25.
28. Wu X, Gu J, Wu TT, et al (2006). Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol, 24, 3789-3798.
29. Xing D, Tan W, Lin D. (2003). Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep, 10, 1615-23.
30. Yang CS. (2000). Vitamin nutrition and gastroesophageal cancer. J Nutr, 130, 338S-9S.
31. Yang CX, Matsuo K, Ito H, et al (2005). Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis, 26, 1285-90.
32. Yu MC, Yuan JM, Lu SC. (2008). Alcohol, cofactors, and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol, 23, S92-S97.
33. Zhang J, Zotz RB, Li Y, et al (2004). Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamouscell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol, 130, 574-80.
34. Zhang JH, Li Y, Guo Y, et al (2003). The association of methylenetetrahydrofolate reductaseC677T polymorphism and esophageal squamous cell carcinoma analyzed by LightCycler. Prog Biochem Biophys, 30, 555-9.